Drreddys Laboratories reported INR23.18B in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
ANI Pharmaceuticals USD 81.77M 5.24M Jun/2025
Aurora Cannabis CAD 45.63M 7.45M Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Canopy Growth CAD 40.12M 504K Jun/2025
Cipla INR 13.12B 792M Jun/2025
Corcept Therapeutics USD 103.85M 13.19M Jun/2025
Drreddys Laboratories INR 23.18B 1.59B Jun/2025
GlaxoSmithKline GBP 2.14B 80M Jun/2025
Hikma Pharmaceutical USD 288M 8M Dec/2024
Novartis USD 3.44B 384M Jun/2025
Pacira USD 77.19M 9.58M Jun/2025
Prestige Brands USD 28.46M 35.6M Jun/2025
Richter Gedeon HUF 51.12B 4.36B Sep/2024
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Supernus Pharmaceuticals USD 62.22M 27.72M Jun/2025
Teva Pharmaceutical Industries USD 959M 40M Jun/2025